| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |